STOCK TITAN

Virgin Galactic Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Virgin Galactic Holdings, Inc. (NYSE: SPCE) reported its financial results for Q4 and full year 2022, revealing a net loss of $500 million for the year, up from $353 million in 2021. Q4 2022 net loss was $151 million, worsening from a $81 million loss in Q4 2021. Despite challenges, the company has a strong cash position with $980 million as of December 31, 2022. Operating activities consumed $380 million in cash over the year. The company is on track to launch commercial services in Q2 2023 following successful validation flights. Significant investments were made in R&D, totaling $314 million for the full year, highlighting ongoing development efforts.

Positive
  • Strong cash position of $980 million as of December 31, 2022.
  • Successful validation flights completed, indicating readiness for commercial service in Q2 2023.
Negative
  • Net loss of $500 million for full year 2022, a $147 million increase from 2021.
  • Operating activities consumed $380 million in cash, significantly higher than $231 million in 2021.
  • Adjusted EBITDA of $(431) million for the year, worsening from $(245) million in 2021.
  • Commercial Service Remains on Track for Q2 2023
  • Enhancements to VMS Eve and VSS Unity Complete
  • VMS Eve Has Returned to Spaceport America to Begin Flights with VSS Unity

ORANGE COUNTY, Calif.--(BUSINESS WIRE)-- Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the "Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

Michael Colglazier, Chief Executive Officer of Virgin Galactic said, “It is great to see our mothership back in the skies, and we are thrilled to have VMS Eve rejoin spaceship Unity back home at Spaceport America. With our enhancement program complete and validation flights underway, we remain on track to launch commercial service in the second quarter of 2023. Our near-term objective for commercial spaceline operations is to safely deliver recurring flights with our current ships while providing an unrivaled experience for private astronauts and researchers.”

Fourth Quarter 2022 Financial Highlights

  • Cash position remains strong, with cash and cash equivalents and marketable securities of $980 million as of December 31, 2022.
  • Net loss of $151 million, compared to a $81 million net loss in the fourth quarter of 2021.
  • GAAP selling, general and administrative expenses of $47 million, compared to $38 million in the fourth quarter of 2021. Non‐GAAP selling, general and administrative expenses of $39 million in the fourth quarter of 2022, compared to $29 million in the fourth quarter of 2021.
  • GAAP research and development expenses of $103 million, compared to $40 million in the fourth quarter of 2021. Non‐GAAP research and development expenses of $99 million in the fourth quarter of 2022, compared to $36 million in the fourth quarter of 2021.
  • Adjusted EBITDA totaled $(133) million, compared to $(65) million in the fourth quarter of 2021.
  • Net cash used in operating activities totaled $131 million, compared to $65 million in the fourth quarter of 2021.
  • Cash paid for capital expenditures totaled $4 million, compared to $2 million in the fourth quarter of 2021.
  • Free cash flow totaled $(135) million, compared to $(67) million in the fourth quarter of 2021.
  • Generated $3.8 million in gross proceeds through the issuance of 0.7 million shares of common stock as part of the Company's at-the-market offering program announced on August 4, 2022.

Full Year 2022 Financial Highlights

  • Net loss of $500 million, compared to a $353 million net loss in 2021.
  • GAAP selling, general and administrative expenses of $175 million, compared to $167 million in 2021. Non-GAAP selling, general and administrative expenses of $143 million, compared to $121 million in 2021.
  • GAAP research and development expenses of $314 million, compared to $144 million in 2021. Non-GAAP research and development expenses of $300 million, compared to $129 million in 2021.
  • Adjusted EBITDA totaled $(431) million, compared to $(245) million in 2021.
  • Net cash used in operating activities totaled $380 million, compared to $231 million in 2021.
  • Cash paid for capital expenditures totaled $16 million, compared to $5 million in 2021.
  • Free cash flow totaled $(397) million, compared to $(235) million in 2021.
  • Generated $103.3 million in gross proceeds through the issuance of 16.3 million shares of common stock as part of the Company's at-the-market offering program announced on August 4, 2022.
  • Generated $425 million in gross proceeds through the issuance of convertible senior notes on January 19, 2022.

Recent Updates and Full Year Business Highlights

  • Commercial service remains on track for Q2 2023.
  • On November 2, 2022, announced Bell Textron and Qarbon Aerospace as primary suppliers to provide major subassemblies for Delta Class spaceships.
  • On August 2, 2022, announced land in New Mexico secured for a new astronaut campus and training facility.
  • On July 14, 2022, announced new final assembly manufacturing facility in Mesa, Arizona for the Delta Class spaceships.
  • On July 6, 2022, announced agreement with Aurora Flight Sciences to build the next generation motherships.

Financial Guidance

The following forward-looking statements reflect our expectations for the first quarter of 2023 as of February 28, 2023 and are subject to substantial uncertainty. Our results are based on assumptions that we believe to be reasonable as of this date, but may be materially affected by many factors, as discussed below in “Forward-Looking Statements.”

  • Forecasted free cash flow for the first quarter of 2023 is expected to be in the range of $(135) million to $(145) million.

Non-GAAP Financial Measures

In addition to the Company's results prepared in accordance with generally accepted accounting principles in the United States (GAAP), the Company is also providing certain non-GAAP financial measures. A discussion regarding the use of non-GAAP financial measures and a reconciliation of such measures to the most directly comparable GAAP information is presented later in this press release.

Conference Call Information

Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial +1 844 200 6205 or +1 646 904 5544 and enter the conference ID number 237767. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at https://investors.virgingalactic.com/events-and-presentations/. A recording of the webcast will also be available following the conference call.

About Virgin Galactic Holdings

Virgin Galactic is an aerospace and space travel company, pioneering human spaceflight for private individuals and researchers with its advanced air and space vehicles. It is developing a spaceflight system designed to connect the world to the love, wonder and awe created by space travel and to offer customers a transformative experience. You can find more information at https://www.virgingalactic.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our spaceflight systems, expected flight schedule, timing of commercial launch, completion of our Delta class spaceship and motherships, our objectives for future operations and the Company’s financial forecasts, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Fourth Quarter 2022 Financial Results

 

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except for per share amounts)

 
 

 

 

Three Months Ended

 

Year Ended

 

 

December 31,

 

December 31,

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

Revenue

 

$

869

 

 

$

141

 

 

$

2,312

 

 

$

3,292

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Customer experience

 

 

1,169

 

 

 

2

 

 

 

1,906

 

 

 

272

 

Selling, general and administrative

 

 

47,298

 

 

 

38,311

 

 

 

175,118

 

 

 

166,814

 

Research and development

 

 

102,596

 

 

 

40,226

 

 

 

314,174

 

 

 

144,223

 

Depreciation and amortization

 

 

3,117

 

 

 

2,883

 

 

 

11,098

 

 

 

11,518

 

Total operating expenses

 

 

154,180

 

 

 

81,422

 

 

 

502,296

 

 

 

322,827

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

(153,311

)

 

 

(81,281

)

 

 

(499,984

)

 

 

(319,535

)

 

 

 

 

 

 

 

 

 

Interest income

 

 

6,175

 

 

 

423

 

 

 

12,502

 

 

 

1,208

 

Interest expense

 

 

(3,206

)

 

 

(6

)

 

 

(12,130

)

 

 

(25

)

Change in fair value of warrants

 

 

 

 

 

 

 

 

 

 

 

(34,650

)

Other income, net

 

 

51

 

 

 

72

 

 

 

58

 

 

 

182

 

Loss before income taxes

 

 

(150,291

)

 

 

(80,792

)

 

 

(499,554

)

 

 

(352,820

)

Income tax expense

 

 

529

 

 

 

5

 

 

 

598

 

 

 

79

 

Net loss

 

 

(150,820

)

 

 

(80,797

)

 

 

(500,152

)

 

 

(352,899

)

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

167

 

 

 

118

 

 

 

(146

)

 

 

129

 

Unrealized gain (loss) on marketable securities

 

 

2,916

 

 

 

(1,566

)

 

 

(5,311

)

 

 

(2,003

)

Total comprehensive loss

 

$

(147,737

)

 

$

(82,245

)

 

$

(505,609

)

 

$

(354,773

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.55

)

 

$

(0.31

)

 

$

(1.89

)

 

$

(1.43

)

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding:

 

 

 

 

 

 

 

 

Basic and diluted

 

 

274,902

 

 

 

257,888

 

 

 

263,947

 

 

 

247,619

 

 

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(In thousands)

 

 

 

 

 

 

December 31,

 

 

 

2022

 

 

 

2021

 

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

302,291

 

 

$

524,481

 

Restricted cash

 

 

40,336

 

 

 

25,549

 

Marketable securities, short-term

 

 

606,716

 

 

 

79,418

 

Inventories

 

 

24,043

 

 

 

29,668

 

Prepaid expenses and other current assets

 

 

28,228

 

 

 

19,476

 

Total current assets

 

 

1,001,614

 

 

 

678,592

 

Marketable securities, long-term

 

 

30,392

 

 

 

301,463

 

Property, plant and equipment, net

 

 

53,658

 

 

 

47,498

 

Other non-current assets

 

 

54,274

 

 

 

41,281

 

Total assets

 

$

1,139,938

 

 

$

1,068,834

 

Liabilities and Stockholders' Equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

 

16,326

 

 

 

9,237

 

Accrued liabilities

 

 

61,848

 

 

 

28,787

 

Customer deposits

 

 

102,647

 

 

 

90,863

 

Other current liabilities

 

 

3,232

 

 

 

2,636

 

Total current liabilities

 

 

184,053

 

 

 

131,523

 

Non-current liabilities:

 

 

 

 

Convertible senior notes, net

 

 

415,720

 

 

 

 

Other long-term liabilities

 

 

59,942

 

 

 

43,047

 

Total liabilities

 

 

659,715

 

 

 

174,570

 

Stockholders' Equity

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

28

 

 

 

26

 

Additional paid-in capital

 

 

2,111,316

 

 

 

2,019,750

 

Accumulated deficit

 

 

(1,623,795

)

 

 

(1,123,643

)

Accumulated other comprehensive loss

 

 

(7,326

)

 

 

(1,869

)

Total stockholders' equity

 

 

480,223

 

 

 

894,264

 

Total liabilities and stockholders' equity

 

$

1,139,938

 

 

$

1,068,834

 

 

 

 

VIRGIN GALACTIC HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

 

Three Months Ended

 

Year Ended

 

 

December 31,

 

December 31,

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(150,820

)

 

$

(80,797

)

 

$

(500,152

)

 

$

(352,899

)

Stock-based compensation

 

 

11,221

 

 

 

13,101

 

 

 

45,709

 

 

 

61,805

 

Depreciation and amortization

 

 

3,123

 

 

 

2,883

 

 

 

11,098

 

 

 

11,518

 

Amortization of debt issuance costs

 

 

532

 

 

 

 

 

 

1,998

 

 

 

 

Change in fair value of warrant liability

 

 

 

 

 

 

 

 

 

 

 

34,650

 

Other non-cash items

 

 

538

 

 

 

53

 

 

 

10,800

 

 

 

11

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Inventories

 

 

(1,192

)

 

 

(363

)

 

 

5,625

 

 

 

815

 

Other current and non-current assets

 

 

(5,063

)

 

 

(9,807

)

 

 

(2,810

)

 

 

(3,465

)

Accounts payable and accrued liabilities

 

 

11,323

 

 

 

6,111

 

 

 

35,151

 

 

 

7,935

 

Customer deposits

 

 

(1,324

)

 

 

5,504

 

 

 

11,784

 

 

 

7,652

 

Other current and long-term liabilities

 

 

420

 

 

 

(1,811

)

 

 

556

 

 

 

1,215

 

Net cash used in operating activities

 

 

(131,242

)

 

 

(65,126

)

 

 

(380,241

)

 

 

(230,763

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(4,183

)

 

 

(2,183

)

 

 

(16,489

)

 

 

(4,635

)

Purchases of marketable securities

 

 

(99,620

)

 

 

(96,752

)

 

 

(704,565

)

 

 

(382,884

)

Proceeds from maturities and calls of marketable securities

 

 

140,277

 

 

 

 

 

 

434,889

 

 

 

 

Net cash provided by (used in) investing activities

 

 

36,474

 

 

 

(98,935

)

 

 

(286,165

)

 

 

(387,519

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Payments of finance lease obligations

 

 

(102

)

 

 

(35

)

 

 

(234

)

 

 

(140

)

Proceeds from convertible senior notes

 

 

 

 

 

 

 

 

425,000

 

 

 

 

Debt issuance costs

 

 

 

 

 

 

 

 

(11,278

)

 

 

 

Purchase of capped call

 

 

 

 

 

 

 

 

(52,318

)

 

 

 

Repayment of commercial loan

 

 

 

 

 

 

 

 

(310

)

 

 

(310

)

Proceeds from issuance of common stock

 

 

3,753

 

 

 

 

 

 

103,326

 

 

 

500,000

 

Proceeds from issuance of common stock pursuant to stock options exercised

 

 

 

 

 

1,124

 

 

 

49

 

 

 

19,980

 

Withholding taxes paid on behalf of employees on net settled stock-based awards

 

 

(505

)

 

 

(7,622

)

 

 

(3,984

)

 

 

(23,401

)

Transaction costs related to issuance of common stock

 

 

(111

)

 

 

(19

)

 

 

(1,248

)

 

 

(6,772

)

Net cash provided by (used in) financing activities

 

 

3,035

 

 

 

(6,552

)

 

 

459,003

 

 

 

489,357

 

Net decrease in cash, cash equivalents and restricted cash

 

 

(91,733

)

 

 

(170,613

)

 

 

(207,403

)

 

 

(128,925

)

Cash, cash equivalents and restricted cash at beginning of period

 

 

434,360

 

 

 

720,643

 

 

 

550,030

 

 

 

678,955

 

Cash, cash equivalents and restricted cash at end of period

 

$

342,627

 

 

$

550,030

 

 

$

342,627

 

 

$

550,030

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

302,291

 

 

$

524,481

 

 

$

302,291

 

 

$

524,481

 

Restricted cash

 

 

40,336

 

 

 

25,549

 

 

 

40,336

 

 

 

25,549

 

Cash, cash equivalents and restricted cash

 

$

342,627

 

 

$

550,030

 

 

$

342,627

 

 

$

550,030

 

USE OF NON-GAAP FINANCIAL MEASURES

This press release references certain financial measures that are not prepared in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA, non-GAAP selling, general and administrative expenses, non-GAAP research and development expenses and free cash flow. The Company defines Adjusted EBITDA as earnings before interest expense, income taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general and administrative expenses as selling, general and administrative expenses other than stock-based compensation and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. It defines free cash flow as net cash provided by operating activities less capital expenditures. None of these non-GAAP financial measures is a substitute for or superior to measures prepared in accordance with GAAP and should not be considered as an alternative to any other measures derived in accordance with GAAP.

The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.

A reconciliation of net loss to Adjusted EBITDA for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, is set forth below (in thousands):

 

 

Three Months Ended

 

Year Ended

 

 

December 31,

 

December 31,

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Net loss

 

$

(150,820

)

 

$

(80,797

)

 

$

(500,152

)

 

$

(352,899

)

Income tax expense

 

 

529

 

 

 

5

 

 

 

598

 

 

 

79

 

Interest expense

 

 

3,206

 

 

 

6

 

 

 

12,130

 

 

 

25

 

Depreciation and amortization

 

 

3,117

 

 

 

2,883

 

 

 

11,098

 

 

 

11,518

 

EBITDA

 

 

(143,968

)

 

 

(77,903

)

 

 

(476,326

)

 

 

(341,277

)

Stock-based compensation

 

 

11,221

 

 

 

13,101

 

 

 

45,709

 

 

 

61,805

 

Change in fair value of warrants

 

 

 

 

 

 

 

 

 

 

 

34,650

 

Adjusted EBITDA

 

$

(132,747

)

 

$

(64,802

)

 

$

(430,617

)

 

$

(244,822

)

A reconciliation of selling, general and administrative expenses to non-GAAP selling, general and administrative expenses for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, is set forth below (in thousands):

 

 

Three Months Ended

 

Year Ended

 

 

December 31,

 

December 31,

 

 

2022

 

2021

 

2022

 

2021

Selling, general and administrative expenses

 

$

47,298

 

$

38,311

 

$

175,118

 

$

166,814

Stock-based compensation

 

 

7,887

 

 

9,177

 

 

31,955

 

 

46,181

Non-GAAP selling, general

and administrative expenses

 

$

39,411

 

$

29,134

 

$

143,163

 

$

120,633

A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended December 31, 2022 and 2021 and years ended December 31, 2022 and 2021, respectively, are set forth below (in thousands):

 

 

Three Months Ended

 

Year Ended

 

 

December 31,

 

December 31,

 

 

2022

 

2021

 

2022

 

2021

Research and development expenses

 

$

102,596

 

$

40,226

 

$

314,174

 

$

144,223

Stock-based compensation

 

 

3,334

 

 

3,924

 

 

13,754

 

 

15,624

Non-GAAP research and

development expenses

 

$

99,262

 

$

36,302

 

$

300,420

 

$

128,599

The following table reconciles forecasted net cash used in operating activities to forecasted free cash flow for the three months ending March 31, 2023 (in thousands):

 

 

Forecasted Range

Net cash used in operating activities

 

$(127,000)-$(133,000)

Capital expenditures

 

$(8,000)-$(12,000)

Free cash flow

 

$(135,000)-$(145,000)

_______________

For media inquiries:

Aleanna Crane - Vice President, Communications

Virgingalacticpress@virgingalactic.com

575.800.4422

For investor inquiries:

Eric Cerny - Vice President, Investor Relations

vg-ir@virgingalactic.com

949.774.7637

Source: Virgin Galactic Holdings, Inc.

FAQ

What are Virgin Galactic's financial results for Q4 2022?

Virgin Galactic reported a net loss of $151 million for Q4 2022, up from a $81 million loss in Q4 2021.

When is Virgin Galactic expected to launch commercial service?

Virgin Galactic is on track to launch commercial service in Q2 2023.

What was the total net loss for Virgin Galactic in 2022?

The total net loss for Virgin Galactic in 2022 was $500 million.

How much cash did Virgin Galactic have at the end of 2022?

As of December 31, 2022, Virgin Galactic had a cash position of $980 million.

What were the research and development expenses for Virgin Galactic in 2022?

Research and development expenses totaled $314 million for the full year 2022, compared to $144 million in 2021.

Virgin Galactic Holdings, Inc.

NYSE:SPCE

SPCE Rankings

SPCE Latest News

SPCE Stock Data

180.33M
27.19M
5.83%
31.42%
24.84%
Aerospace & Defense
Transportation Services
Link
United States of America
TUSTIN